Indications
This is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
Therapeutic Class
Long-acting selective
Indications
Rabeprazole is indicated in-
Duodenal ulcer
Healing of erosive or ulcerative Gastroesophageal Reflux Disease (GERD)
Treatment of symptomatic GERD
Maintenance of healing of erosive or ulcerative GERD
Zollinger-Ellison Syndrome
Helicobacter pylori eradication to reduce the risk of Duodenal Ulcer recurrence.
Therapeutic Class
Proton Pump Inhibitor
Pharmacology
Rabeprazole suppresses gastric acid secretion by inhibiting the
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
